OncoLink, the Web's first cancer resource,provides comprehensive information on coping with cancer, cancer treatments, cancer research advances, continuing medical education, cancer prevention, and clinical trials

OncoLink, the Web's first cancer resource,provides comprehensive information on coping with cancer, cancer treatments, cancer research advances, continuing medical education, cancer prevention, and clinical trials

Dostarlimab-gxly (Jemperli®) is a type of monoclonal antibody therapy. It works as a form of immunotherapy by binding to either the programmed death receptor-1 (PD-1) or PD-ligand 1 (PD-L1) found on T-cells. Your tumor will need to be tested for and have a certain genetic mutation called Deficient mismatch repair (dMMR).

Jun 6, 2024 · Tarlatamab-dlle is a type of medication called a bispecific T-cell engager (BiTE) antibody. This medication helps your body’s T-cells (part of your immune system) target and kill cells that have the DLL3 protein on their surface.

Nov 20, 2024 · Este artículo proporciona una descripción general de los marcadores tumorales que pueden usarse para diagnosticar, predecir el pronóstico y evaluar el tratamiento del cáncer de ovario.

Jun 19, 2023 · Fludarabine is a chemotherapy medication used in the treatment of b-cell chronic lymphocytic leukemia (CLL).

Feb 10, 2025 · Fam-trastuzumab deruxtecan-nxki is an antibody conjugate (an antibody with a cell-killing medication attached to it) directed against a protein called HER2 (human epidermal growth factor receptor 2), found on the surface of some cancer cells.

Dec 2, 2024 · El sistema de puntuación de Nottingham se utiliza para asignar a cada cáncer de mama una puntuación de Nottingham. La puntuación de Nottingham también se denomina grado o puntuación histológica y mide la agresividad de un tumor.

Jun 14, 2024 · Gemcitabine is a chemotherapy medication used in the treatment of ovarian cancer, breast, non small cell lung cancer, and pancreatic cancer.

Jan 31, 2024 · OncoLink, the Web's first cancer resource,provides comprehensive information on coping with cancer, cancer treatments, cancer research advances, continuing medical education, cancer prevention, and clinical trials